Latest Prescription Drugs news
Biden Unveils New ‘Test to Treat’ Plan as Key Part of New COVID-19 Strategy
posted March 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Risk for Progression to Severe COVID-19 Lower With Nirmatrelvir + Ritonavir
posted March 1st
by modernClinician Editorial Team
by modernClinician Editorial Team
AAAAI: Add-On Inhaled Glucocorticoid Lowers Severe Asthma Exacerbations
posted March 1st
by modernClinician Editorial Team
by modernClinician Editorial Team
ACP Issues Final Practice Points for Remdesivir Use in COVID-19
posted March 1st
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis Related Articles
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
Low Hydroxychloroquine Intake, Blood Levels Linked to ASCVD Risk in Lupus Monthly Specialist Briefings
Stay Connected
